Thermo Fisher to buy Life Technologies in $13.6 billion cash deal
Thermo Fisher Scientific will spend $13.6 billion to buy genetic testing equipment maker Life Technologies in a cash deal that will create a giant company serving research and specialty diagnostics.
That price does not count $2.2 billion in debt that will be assumed as part of the deal.
The Waltham, Mass., company says it plans to pay $76 in cash for each share of Life Technologies, which is based in Carlsbad, Calif.
Life Technologies Corp. shareholders and regulators still need to approve the deal, expected to close early next year. Thermo Fisher says it has obtained commitments for bridge financing for the deal from JP Morgan and Barclays.
The boards for both companies have already approved the deal.
Life Technologies serves customers in scientific research, genetic analysis and applied science.
News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.
Join the Conversation!
Want to share your thoughts, add context, or connect with others in your community? Create a free account to comment on stories, ask questions, and join meaningful discussions on our new site.
Related Articles
Leave a Reply
You must be logged in to post a comment.